Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243418
What this trial is testing
Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study
Who this might be right for
CTIT-Chemotherapy Induced ThrombocytopeniaBreast Cancer
Fujian Cancer Hospital 72